Blockade of CSF-1 and CSF-1R in combination with chemotherapy improved survival and reduced the metastatic frequency in a breast cancer model and this response correlated with an increase in cytotoxic CD8+ T cells within the tumours [24]. Here, CSF1R is linked to neoplasm.